Mechanistic insight of SARS-CoV-2 infection using human hepatobiliary organoids

Yi Zhao, Xiaoxue Ren, Jing Lu, Minghui He, Zhe Liu, Lina Yi, Mingle Huang, Ming Kuang, Haipeng Xiao, Joseph J.�y. Sung, Xiaoxing Li, Lixia Xu, Jun YuGut 2022 · DOI · OpenAlex

Abstract

Clinical observations during the COVID-19 pandemic revealed significant liver dysfunction in patients, characterized by elevated bilirubin and liver enzymes. This study utilizes human liver and biliary organoids to investigate whether these effects result from direct viral infection. The researchers demonstrate that SARS-CoV-2 directly infects hepatocytes and cholangiocytes, utilizing ASGR1 as an alternative entry receptor in the liver. Infection triggers robust proinflammatory signaling and disrupts bile acid homeostasis, providing a molecular explanation for the clinical manifestations of liver damage in COVID-19.

Introduction

Early clinical reports of COVID-19 highlighted a high prevalence of abnormal liver function tests, specifically elevated gamma-glutamyltransferase (GGT) and total bilirubin. A central question emerged: is liver damage a secondary effect of systemic inflammation, or does SARS-CoV-2 directly invade liver tissues? Due to the limitations of animal models and the difficulty of studying live infections in patients, this study employed 3D human organoid models—miniature, lab-grown versions of human organs—to provide a mechanistic look at viral-host interactions in the hepatobiliary system.

Methods and Experimental Design

The research team derived five liver organoid lines (hepatocytes) and two biliary organoid lines (cholangiocytes) from healthy human tissue. These 3D structures mimic the physiological architecture and functional properties of the human liver.

Experimental workflow and characterization of SARS-CoV-2 infection in human hepatobiliary organoids.

The organoids were challenged with a patient-isolated strain of SARS-CoV-2. The study employed a multi-modal analytical approach:

  • Imaging: Immunofluorescence (IF) and Transmission Electron Microscopy (TEM) were used to visualize viral proteins and individual particles.
  • Molecular Analysis: RT-qPCR measured viral replication kinetics, while RNA sequencing (RNA-seq) profiled the transcriptomic response of the host cells.

Key Results

Direct Viral Infection and Replication

Both liver and biliary organoids were found to be highly susceptible to SARS-CoV-2. Viral gene copies increased dramatically within the first 24 hours post-infection and remained stable for up to 96 hours. TEM imaging provided definitive proof of infection, capturing viral particles within membrane-bound vesicles and at the apical and basolateral surfaces of the cells.

Alternative Entry via ASGR1

A significant finding was the identification of ASGR1 (Asialoglycoprotein Receptor 1) as a functional receptor for viral entry in the liver. While the primary ACE2 receptor is highly expressed in biliary cells, its expression is relatively low in hepatocytes. The discovery of ASGR1 explains how the virus achieves high viral loads in liver tissues despite lower ACE2 levels.

Transcriptomic Disruption and Proinflammatory Response

RNA-seq analysis revealed that SARS-CoV-2 infection induces a "robust induction" of proinflammatory cytokines and activates pathways such as NF-κB and TNF signaling. This suggests that the virus directly causes local inflammation within the liver tissue.

Ultrastructural evidence and transcriptomic profiling of infected organoids.

Furthermore, the infection significantly altered genes involved in bile acid transport and steroid hormone biosynthesis. Specifically, the downregulation of the transporter gene SLCO4C1 and the upregulation of UGT1A1 provide a direct mechanistic link to the hyperbilirubinemia (elevated bilirubin) observed in severe COVID-19 cases.

Discussion and Conclusion

This study confirms that SARS-CoV-2 can directly infect and replicate within human hepatobiliary tissues, leading to cell death (apoptosis) and inflammatory signaling. By identifying ASGR1 as an alternative receptor and mapping the disruption of bile homeostasis, the researchers have provided a molecular basis for the liver dysfunction seen in COVID-19 patients.

While organoids provide high-fidelity tissue-specific insights, the model lacks the systemic immune context present in a living patient. Future research using these models could investigate the long-term persistence of the virus in the liver and its potential role in "Long COVID" symptoms.

Summary updated

BibTeX
@inproceedings{zhao2022mechanistic,
  author = {Yi Zhao and Xiaoxue Ren and Jing Lu and Minghui He and Zhe Liu and Lina Yi and Mingle Huang and Ming Kuang and Haipeng Xiao and Joseph J.�Y. Sung and Xiaoxing Li and Lixia Xu and Jun Yu and Joseph JY Sung},
  title = {{Mechanistic insight of SARS-CoV-2 infection using human hepatobiliary organoids}},
  booktitle = {Gut},
  year = {2022},
  doi = {10.1136/gutjnl-2021-326617},
}
Figure